# Primary cutaneous anaplastic large cell lymphoma: Clinical response with low dose brentuximab vedotin on a patient receiving hemodialysis

**Authors:** Claire Fason, Stephen Tyring, Auris O. Huen

PMC · DOI: 10.1016/j.jdcr.2025.04.004 · JAAD Case Reports · 2025-04-17

## Full-text entities

- **Diseases:** Primary cutaneous anaplastic large cell lymphoma (MESH:D054446)
- **Chemicals:** brentuximab vedotin (MESH:D000079963)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12310056/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12310056/full.md

## References

8 references — full list in the complete paper: https://tomesphere.com/paper/PMC12310056/full.md

---
Source: https://tomesphere.com/paper/PMC12310056